MRPL12

MRPL12 is a component of the mitochondrial large ribosomal subunit that serves as a central regulator of both mitochondrial translation and transcription, coupling ribosome function with mtDNA-encoded gene expression to control oxidative phosphorylation. MRPL12 integrates into the mitoribosome to support synthesis of respiratory chain subunits, and its loss or mutation (e.g., p.Ala181Val) impairs mitoribosome assembly and mitochondrial translation (PMID:8626705, PMID:23603806). Independent of its ribosomal role, MRPL12 directly binds the mitochondrial RNA polymerase POLRMT to stimulate mtDNA transcription, an interaction regulated by phosphorylation at Y60 (opposed by the phosphatase UBASH3B), acetylation at K163 (written by TIP60, erased by SIRT5), and K63-linked ubiquitination at K150 (mediated by CUL3) (PMID:39343960, PMID:40858596, PMID:37526061). Biallelic MRPL12 mutations cause combined oxidative phosphorylation deficiency through defective mitoribosome incorporation and reduced synthesis of respiratory chain complexes (PMID:23603806).

1. 1996 High

   Establishing that MRPL12 is a mitochondrial ribosomal protein whose disruption impairs mitochondrial ATP production resolved its subcellular assignment and linked it to energy metabolism.

   Evidence Immunofluorescence, cell fractionation, in vitro ribosome co-fractionation, and dominant-negative overexpression with ATP assay in mammalian cells

   PMID:8626705

   Open questions at the time

   • Direct role in translation versus ribosome assembly not distinguished
   • No identification of specific mitoribosome contacts
2. 2005 High

   Genetic epistasis in Drosophila revealed that mRpL12 operates downstream of CycD/Cdk4 and in concert with Hph to drive cell growth through mitochondrial activity, placing mitoribosomal function within a growth-control signaling axis.

   Evidence Loss-of-function screen and epistasis analysis with mitochondrial activity readouts in Drosophila eye

   PMID:15692573

   Open questions at the time

   • Whether CycD/Cdk4 regulation of MRPL12 is direct or transcriptional was not resolved
   • Conservation of this pathway in mammals not tested
3. 2013 High

   Patient-derived p.Ala181Val mutation demonstrated that MRPL12 integrity is required for mitoribosome incorporation and mitochondrial translation of respiratory chain subunits, establishing MRPL12 as a disease gene for combined OXPHOS deficiency.

   Evidence Patient mutation analysis, ribosome subunit fractionation, radiolabeled mitochondrial translation assay, and structural modeling

   PMID:23603806

   Open questions at the time

   • Structural basis of Ala181-mediated elongation factor interaction not resolved at atomic level
   • No rescue experiment to confirm causality of the single mutation
4. 2020 Medium

   Identification of ATF2 as a direct transcriptional activator of the MRPL12 promoter, downstream of p62/p38 signaling, established how upstream stress pathways regulate MRPL12 expression to control mitochondrial gene expression.

   Evidence Promoter binding assay, p38 inhibition, MRPL12 knockdown/overexpression, OXPHOS assay, and tissue-specific p62 knockout mice in renal tubular epithelial cells

   PMID:32805647

   Open questions at the time

   • Single laboratory study
   • Whether ATF2 binding is sufficient or requires co-activators not tested
   • Generalizability beyond renal epithelium unclear
5. 2021 Medium

   Discovery that ING2 regulates MRPL12 ubiquitination and protein stability connected protein turnover mechanisms to MRPL12-dependent mitochondrial respiration and mtDNA transcription.

   Evidence Co-immunoprecipitation, oxygen consumption assay, knockdown/overexpression, and in vivo ischemia-reperfusion injury model

   PMID:34434929

   Open questions at the time

   • The E3 ligase identity was not determined in this study
   • Ubiquitination sites on MRPL12 not mapped
   • Single laboratory
6. 2023 High

   CUL3 was identified as the E3 ubiquitin ligase that K63-ubiquitinates MRPL12 at K150, and MRPL12 was shown to bind ANT3 to stabilize the mitochondrial permeability transition pore, expanding MRPL12's roles beyond translation/transcription to pore regulation.

   Evidence Co-IP, ubiquitination assays with K150 mutagenesis, CUL3 knockdown (for ubiquitination); reciprocal Co-IP, MPTP opening assay, hypoxia/reoxygenation model (for ANT3 interaction)

   PMID:37182101 PMID:37526061

   Open questions at the time

   • Adaptor protein linking CUL3 to MRPL12 not identified
   • Whether K63-ubiquitination affects MRPL12 localization or only stability is unclear
   • ANT3 interaction site on MRPL12 not mapped
7. 2024 High

   Phosphorylation at Y60 was shown to be the switch controlling MRPL12-POLRMT interaction and thus mitochondrial transcription, with UBASH3B identified as the opposing phosphatase, directly linking a specific post-translational modification to the transcriptional function of MRPL12.

   Evidence Mass spectrometry PTM identification, Y60 mutagenesis, Co-IP for POLRMT binding, Kras-driven LUAD mouse models, and patient-derived organoids

   PMID:39343960

   Open questions at the time

   • The kinase that phosphorylates Y60 was not identified
   • Whether Y60 phosphorylation also affects ribosomal integration is untested
8. 2025 High

   Acetylation at K163 by TIP60 (erased by SIRT5) was identified as a second PTM that enhances MRPL12-POLRMT binding and mitochondrial biosynthesis, revealing that two distinct modifications on MRPL12 converge on the same transcriptional interaction.

   Evidence Co-IP for TIP60, SIRT5, and POLRMT; K163 mutagenesis; in vitro and in vivo ccRCC models; metabolic assays

   PMID:40858596

   Open questions at the time

   • Interplay between Y60 phosphorylation and K163 acetylation not examined
   • Structural basis for how K163 acetylation enhances POLRMT binding unknown

• The kinase responsible for MRPL12 Y60 phosphorylation, the structural basis of the MRPL12-POLRMT interface, and whether MRPL12's ribosomal versus extra-ribosomal (POLRMT-binding, ANT3-binding) pools are independently regulated remain unresolved.
• Y60 kinase identity unknown
• No high-resolution structure of MRPL12-POLRMT complex
• Relative contributions of ribosomal vs. extra-ribosomal MRPL12 to OXPHOS not quantified